Skip to main content

To trade in the US, go to polymarket.us

icon for Measles cases in U.S. in 2026?
Climate & Science·Pandemics

Measles cases in U.S. in 2026?

icon for Measles cases in U.S. in 2026?
Climate & Science·Pandemics

Measles cases in U.S. in 2026?

Oct 1

Jan 1, 2027

Oct 1

Jan 1, 2027

Polymarket

$7,888,078 Vol.

Polymarket

$7,888,078 Vol.

↑3.5k

$15,298 Vol.

100%

↑4k

$240,467 Vol.

94%

↑4.5k

$2,197 Vol.

89%

↑4.75k

$206 Vol.

77%

↑5k

$239,723 Vol.

54%

↑7.5k

$191,100 Vol.

13%

↑10k

$6,522,777 Vol.

6%

↑12.5k

$356,354 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission in 2026, driven by declining MMR vaccination coverage and multiple large outbreaks, has pushed confirmed U.S. cases to 3,134 as of early September per CDC surveillance—already exceeding the full-year 2025 record of 2,289. Over 94% of cases involve unvaccinated or unknown-status individuals, with 95% linked to ongoing outbreaks across 47 jurisdictions, concentrated in states such as South Carolina, Pennsylvania, and Utah. Local chains of transmission now dominate over imported cases, reflecting eroded herd immunity thresholds. CDC weekly updates and state health department reports will continue to shape trader views on final 2026 totals, while the November Pan American Health Organization review of U.S. elimination status adds a key milestone that could influence perceived trajectory.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,888,078
End Date
Jan 1, 2027
Market Opened
Jun 30, 2026, 2:17 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission in 2026, driven by declining MMR vaccination coverage and multiple large outbreaks, has pushed confirmed U.S. cases to 3,134 as of early September per CDC surveillance—already exceeding the full-year 2025 record of 2,289. Over 94% of cases involve unvaccinated or unknown-status individuals, with 95% linked to ongoing outbreaks across 47 jurisdictions, concentrated in states such as South Carolina, Pennsylvania, and Utah. Local chains of transmission now dominate over imported cases, reflecting eroded herd immunity thresholds. CDC weekly updates and state health department reports will continue to shape trader views on final 2026 totals, while the November Pan American Health Organization review of U.S. elimination status adds a key milestone that could influence perceived trajectory.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,888,078
End Date
Jan 1, 2027
Market Opened
Jun 30, 2026, 2:17 PM ET

Resolver

0x65070BE91...

Related

icon for Will there be at least 3200+ measles cases in the U.S. by September 30, 2026?

Will there be at least 3200+ measles cases in the U.S. by September 30, 2026?

99%
icon for Will South Sudan have an Ebola case in 2026?

Will South Sudan have an Ebola case in 2026?

60%
icon for New pandemic in 2026?

New pandemic in 2026?

6%

Beware of external links.

Frequently Asked Questions

"Measles cases in U.S. in 2026?" is a prediction market on Polymarket with 12 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "↑3.5k" at 100%, followed by "↑500" at 100%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Measles cases in U.S. in 2026?" has generated $7.9 million in total trading volume since the market launched on Dec 1, 2025. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Measles cases in U.S. in 2026?," browse the 12 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Measles cases in U.S. in 2026?" is "↑3.5k" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "↑500" at 100%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Measles cases in U.S. in 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.